Banque Cantonale Vaudoise Cytokinetics Inc Transaction History

Banque Cantonale Vaudoise

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$32.62 - $40.75 $1,630 - $2,037	-50 Reduced 4.91%	968 $32,000
Q4 2022 Feb 10, 2023	SELL	$35.77 - $51.11 $4,542 - $6,490	-127 Reduced 11.09%	1,018 $47,000
Q3 2022 Oct 17, 2022	BUY	$38.54 - $54.52 $5,703 - $8,068	148 Added 14.84%	1,145 $55,000
Q2 2022 Aug 02, 2022	SELL	$33.93 - $48.92 $15,845 - $22,845	-467 Reduced 31.9%	997 $39,000
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $50,288 - $67,900	1,464 New	1,464 $67,000

404

126M

3.24M

2.14M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.